Whole Exome Sequencing Market Analysis 2019-2027: Thermo Fisher Scientific, Illumina, Centogene, Psomagen, Brooks Automation, Bio-Rad Laboratories, Eurofins Scientific and Stratos Genomics

The global Whole exome sequencing market accounted to US$ 755.68 Mn in 2018 and is expected to grow at a CAGR of 19.8% during the forecast period 2019 – 2027, to account to US$ 3,812.0 Mn by 2027.

The market for whole exome sequencing is expected to grow significantly due to factors such as reduction in time and cost for sequencing, rising need of molecular diagnosis and increasing application in drug discovery are likely to drive the growth of the whole exome sequencing market.

Get PDF sample copy of this Study: https://www.theinsightpartners.com/sample/TIPRE00005519/

Global whole exome sequencing market was segmented by product & service, technology, and application. On the basis of the product & service, the market is segmented as systems, kits and services. Services segment is further sub-segmented into sequencing services and data analysis (bioinformatics) and other services. Based on the technology, the whole exome sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing and other technologies. On the basis of the application, the whole exome sequencing market is segmented into diagnostics, drug discovery & development, personalized medicine and others. Diagnostics segment is further sub-segmented into cancer diagnostics, monogenic (mendelian) disorders diagnostics, monogenic types of diabetes diagnostics and HIV diagnostics and other diagnostics.

The major players operating in the whole exome sequencing market include, Thermo Fisher Scientific Inc., Illumina, Inc., Centogene AG, F. Hoffmann-La Roche AG, Psomagen, Inc. (previuosly Macrogen Corp.), Pacific Biosciences of California, Inc., Brooks Automation, Inc. (GENEWIZ, Inc.), Bio-Rad Laboratories, Inc., Eurofins Scientific and Stratos Genomics. The market has carried out various organic and inorganic growth strategies in the market which has assisted in strengthening their product offering in the market.

Asia Pacific is the fastest growing geographic market and it is expected to be the fastest revenue contributor throughout the forecast period. Asia Pacific is recognized as a developing market for the biotechnology. The growth is driven by countries such as China, and India which are engaged in conducting several studies.

Buy the complete report with Comprehensive table of contents @ https://www.theinsightpartners.com/buy/TIPRE00005519/

Strategic Insights

Organic and inorganic growth strategies were observed in global whole exome sequencing industry. The organic strategies which were conducted more compared to the inorganic strategies for the whole exome sequencing. For instance, in February, 2019, Bio-Rad Laboratories, Inc.’s QXDx AutoDG ddPCR System has been approved by the FDA. The QXDx AutoDG ddPCR System is designed to be flexible, allowing users to run either FDA-cleared in vitro diagnostic tests or lab developed tests on the platform.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.